Skip to main content

Table 1 Primer sequences for qPCR

From: Histone acetylation: a key determinant of acquired cisplatin resistance in cancer

Gene

GeneID

Forward (5′–3′)

Reverse (5′–3′)

PIK3CA

5290

TTGTCGTGCATGTGGGATGT

CTGGTCGCCTCATTTGCTCA

PIK3CB

5291

GTAGACTGGGCCTTTGGAACTT

TGATGAGGCTGGGAAACAAGG

PIK3R1

5295

CCTGGCCTGAGAAGGTTTGG

GTCCCTTGTGAGTGGACGTG

HK2

3099

TTGACCAGGAGATTGACATGGG

CAACCGCATCAGGACCTCA

ENO1

2023

GTACATCTCGCCTGACCAGC

CTGGCTGTGAACTTCTGCCA

XIAP

331

ACGGGCTAAGGTAGGGTAGAG

CTAATGCTGGGGCGGTAGTC

BCL-XL

598

TGCCACCAGGAGAACCACTA

TCTGAGGCCAAGGGAACTGA

HDAC1

3065

ATATCGTCTTGGCCATCCTG

TGAAGCAACCTAACCGATCC

HDAC2

3066

GGGAATACTTTCCTGGCACA

ACGGATTGTGTAGCCACCTC

HDAC3

8841

TGGCATTGACCCATAGCCTG

GCATATTGGTGGGGCTGACT

HDAC4

9759

TCGCTACTGGTACGGGAAAAC

AGAGGGAAGTCATCTTTGGCG

HDAC5

10014

ACTGTTCTCAGATGCCCAGC

TGGTGAAGAGGTGCTTGACG

HDAC6

10013

AGTGGCCGCATTATCCTTATCC

ATCTGCGATGGACTTGGATGG

HDAC7

51564

TTCCTGAGTGCAGGGGTAGT

CATCGCCAGGAGGTTGATGT

HDAC8

55869

ATAACCTTGCCAACACGGCT

CTTGGCGTGATTTCCAGCAC

HDAC9

9734

ACTGAAGCAACCAGGCAGTC

TTCACAGCCCCAACTTGTCC

HDAC10

83933

CTGGCCTTTGAGGGGCAAAT

CAGCAGCGTCTGTACTGTCA

HDAC11

79885

CCGGAAAATGGGGCAAAGTG

TAAGATAGCGCCTCGTGTGC

HAT1

8520

AATGGCGGGATTTGGTGCTA

TCATCCCCAAAGAGTTGATGGG

KAT2A

2648

TCGAGTTCCATGTCATCGGC

TCAAGGCCAGAGTCTTGTGC

KAT2B

8850

GAATCGCCGTGAAGAAAGCG

TTATTTGCTGCAGGTCGGCT

KAT5

10524

AGCGTGAAGGACATCAGTGG

AGTCCGTTCTTAGTGGGGGT

CREBBP

1387

TGTTTTCGCGAGCAGGTGA

GTGCTGTCATTCGCCGAGA

EP300

2033

GCAGTGTGCCAAACCAGATG

GGGTTTGCCGGGGTACAATA

KAT8

84148

TCGGAGAAACGTACCTGTGC

TCTTGTCTACCCACTCGTCCA

RPS13

6207

GCTCTCCTTTCGTTGCCTGA

ACTTCAACCAAGTGGGGACG